DNA-BASED HYBRID LIQUID CRYSTALLINE NANO ORGANOMETALLIC COMPOSITES FOR TARGETED DRUG DELIVERY IN NEUTRON CAPTURE THERAPY
DOI:
https://doi.org/10.22159/ijpps.2017v9i6.17991Keywords:
Nanotechnology, Targeted drug delivery, Nanosystem, Boron neutron capture therapy, Gadolinium (Gd)Abstract
Objective: The aim of this work was focused on the obtaining a DNA-based hybrid nano liquid crystalline organometallic composites for targeted drug delivery in neutron capture therapy.
Methods: The formation of a cholesteric liquid crystalline DNA (CLCD-DNA) dispersion has performed using ultrasonic depolymerized calf thymus DNA(MW-0.6-0.8×106Da)2×10-7M, mixing with polyethylene glycol8.5×10-5M, dissolved in the 0.3 M NaCl solution and incubated over 1,0 h at 20 °C. CLCD-DNA formation process was determined and controlled by measuring absorption value of circular dichroism (CD) spectrum in the range of 350-600 nm. The organometallic DNA-Gd compound was formed by processing the obtained CLCD-DNA with 2.49 × 10-4M, 4.97 × 10-4M, 9.8 × 10-4 M, 1.48× 10-3M, 2.92 × 10-3M GdCl3 aqueous solutions. CLCD-DNA-gadolinium complex formation process was registered over the appearance of 2nd amplitude in the CD spectrum. DNA-Gd complex dispersion toxicity was evaluated over 40 min, 24h and 72h incubation with 1×106cells in the RPMI-40 medium supplemented with 3×10-4 M Gd3+.
Results: The obtained CLCD-DNA-Gd (d~500 nm) particles was shown less toxicity and higher viability percentage of macrophages after 40 min incubation with CLCD-DNA-Gd contains Gd3+ions concentration 3×10-4 M showed 100% viability and after 72 h ours approximately 89%. The cells immobilized with CLCD-DNA-Gd particles contains 3×10-4M Gd3+, neutron irritation was caused a 100% cell deaths.
Conclusion: Obtained relatively stable, non-cytotoxic drug forms with a maximum local concentration of gadolinium (400 µg/ml). The effectiveness of these nanosystems for targeted drug delivery has markedly superior efficacy than 10B and other products were based on gadolinium.
Downloads
References
Zakharov MA, Yevdokimov YuM, Skuridin SG. Nanotechnology based on nucleic acids. Proceedings RAS 2006;2:112.
Evathi Sundaramoorthy, Madhulatha Vuyyuru, Magharla Dasaratha Dhanaraju. Carbon nanotube: a flexible approach for nanomedicine and drug delivery. Asian J Pharm Clin Res 2015;8:25-31.
Zakharov MA, Yevdokimov YuM, Skuridin SG, NechipurenkoYuD. Nanotechnology based on spatially fixed ds DNA (RNA) molecules. Report of the OECD workshop on the safety of manufactured nanomaterials: Washington DC; 2005. p. 149.
Lafontaine I, Lavery R. Optimization of nucleic acid sequences. Biophys J 2000;79:680–5.
Yevdokimov YuM, Skuridin SG, Lortkipanidze GB. Invited article liquid-crystalline dispersions of nucleic acids. Liquid Cryst 1992;12:1-16.
Yevdokimov YuM, Salyanov VI, Zakharov MA. A novel type of microscopic size chip based on double-stranded nucleic acids. Lab Chip 2001;1:35-41.
Tokumitsu H, Ichikawa H, Saha TK, Fukumori Y, Block LH. Design and preparation of gadolinium-loaded chitosan particles for cancer neutron capture therapy. STP Pharma Sci 2000;10:39-49.
Goortley T, Zamenhof R, Nikjoo H. Calculated DNA damage from gadolinium auger electrons and relation to dose distributions in a head phantom. Int J Radiat Biol 2004;80:933-40.
Yasui LS, Andorf C, Schneider L, Kroc T, Lennox A, Saroja KR. Gadoliniumneutron capture in glioblastoma multiforme cells. Int J Radiat Biol 2008;3;84:1130–9.
Justin K Greisberg, Jennifer Moriatis Wolf, James Wyman, Lijun Zou, Richard M Terek. Gadolinium inhibits thymidine incorporation and induces apoptosis in chondrocytes. J Orthop Res 2001;19:797-801.
Tokumitsu H, Hiratsuka J, Sakurai Y, Kobayashi T, Ichikawa H, Fukumori Y. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett 2000;150:177-82.
Saha TK, Jono K, Ichikawa H, Fukimori Y. Preparation and evaluation of glutaraldehyde cross-linked chitosan microspheres as a gadolinium reservoir for neutron capture therapy. Chem Pharm Bull 1998;46:537–9.
Justin K Greisberg, Jennifer Moriatis Wolf, James Wyman, Lijun Zou, Richard M Terek. Gadolinium inhibits thymidine incorporation and induces apoptosis in chondrocytes. J Orthop Res 2001;19:797-801.
Leclercq F, Cohen-Ohana M, Mignet N, Sbarbati A, Herscovici J, Scherman D, et al. design, synthesis, and evaluation of gadolinium cationic lipids as tools for biodistribution studies of gene delivery complexes. Bioconjug Chem 2003;14:112-9.
Yuri Evdokimov. Liquid crystal forms of DNA and their biological role. Liquid Crystals 2003;3:10-47.
Yevdokimov YM, Salyanov VI, Kondrashina OV, Borshevsky VI, Semenov SV, Gasanov AA, et al. Particles of liquid-crystalline dispersions formed by (nucleic acid–rare earth element) complexes as a potential platform for neutron capture therapy. Int J Biol Macromol 2005;37:165-73.
Bekov GI Boitsov AA, Bolshov MA. Spectral analysis of pure substances, HI Silberstein. editor. SPb: Chemistry; 1994.
Lefkovits I, Pernis BV, Trucco M. Immunological research methods. M: Mir; 1988.
Adams RLP, Laboratory techniques in biochemistry and molecular biology. Vol. 8. NY: Elsevier; 1990.
Contribution adhesion on glass luminolchemiluminescence in whole blood stimulated by the addition of barium sulfate. Piryazev AP, Vladimirov YA, Sherstnev MP. II Congress of Russian biophysicists. abstracts. M. Research Institute of physicochemical medicine, theministry of health of the Russian Federation; 1999.
Klimov AA. Method of fluorescent nanoscopy. Patent RF â„– RU2305270C2; 2007.
Rima W, Sancey L, Aloy MT, Armandy E, Alcantara GB, Epicier T, et al. Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials 2013;34:181–95.
Salyanov VI, Evseev AI, Popenko VI, Gasanov AA, Dembo KA, Kondrashin OV, et al. Some of the characteristics of gadolinium complexes with linear DNA and liquidcrystal forms. Biophysics 2007;52:452-9.
Evdokimov YuM, Salyanov VI, Nechipurenko JD. Molecular structure (superstructure) with controlled properties on the basis of double-stranded nucleic acids. Mol Biol 2003;37:340-55.
Nematovich KJ, Alekseevich КA, Influence of neutron capture therapy to biological subjects. Eur Sci Rev 2016;3:218–20.
Kudryashov Yu. Radiation Biophysics (ionizing radiation). M: Fizmatlit; 2003.
Podlyashuk EL. Application of radiotherapy in the treatment of non-neoplastic diseases, malignant and benign skin tumors. Radiol Practice 2000;3:41-3.
Jessy Shaji, Ipshita Menon. Recent advances in nanocarrier based therapeutic and diagnostic tools for colorectal cancer. Int J Curr Pharm Res 2015;7:9-16.
Published
How to Cite
Issue
Section
